Mazor Robotics Ltd (MZOR)

NASDAQ
58.23
0.00(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    58.21 - 58.28

MZOR Overview

Prev. Close
58.26
Day's Range
58.21-58.28
Revenue
59.41M
Open
58.25
52 wk Range
0-0
EPS
-0.83
Volume
0
Market Cap
1.55B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
545,607
P/E Ratio
-
Beta
1.22
1-Year Change
0%
Shares Outstanding
53,074,267
Next Earnings Date
-
What is your sentiment on Mazor Robotics Ltd?
or
Market is currently closed. Voting is open during market hours.

Mazor Robotics Ltd News

  • Premarket analyst action - healthcare
    • BySeeking Alpha-

    CytomX Therapeutics (NASDAQ:CTMX) initiated with Buy rating and $38 (46% upside) price target at SunTrust. Globus Medical (NYSE:GMED) initiated with Overweight rating and $65 (17%...

  • Key events next week - healthcare (continued #5)
    • BySeeking Alpha-

    Tuesday (3/13): Barclays (LON:BARC) Global Healthcare Conference, Miami (3 days). Cross Country Healthcare (NASDAQ:CCRN); Eli Lilly; Spark Therapeutics (NASDAQ:ONCE); Fresenius...

Mazor Robotics Ltd Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellNeutralStrong Buy
Technical IndicatorsSellStrong SellStrong SellStrong SellBuy
SummaryStrong SellStrong SellStrong SellSellStrong Buy

Mazor Robotics Ltd Company Profile

Mazor Robotics Ltd Company Profile

Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include Renaissance Guidance System, which can improve the execution and outcomes in a wide variety of procedures, including percutaneous degenerative repair, pedicle screw fixation for complex spinal deformity, and vertebral augmentation; Mazor X, the Surgical Assurance Platform for Spine Surgery. Furthermore, the Company developed the Renaissance Brain Module, an application of its Renaissance System that provides control over the insertion of surgical instruments during brain surgery.

Read More
  • anybody knows why the yesterday it fell 6%?
    3
    • yeah, that should have been -20%
      0
  • Target price 34.5-35. In 5-6 weeks
    2
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.